Levi & Korsinsky Alert Investors of Ongoing Cardlytics Class Action Lawsuit

Levi & Korsinsky is warning Cardlytics investors about an ongoing class-action lawsuit with a lead plaintiff deadline of March 25, 2025. The lawsuit alleges that Cardlytics made false and misleading statements regarding its business and prospects, which ultimately led to investors suffering losses.

Investors who purchased Cardlytics securities between November 1, 2018, and December 8, 2021, are encouraged to participate in the lawsuit. The law firm Levi & Korsinsky is representing the lead plaintiff in this case. The lawsuit claims that Cardlytics failed to disclose important information to investors, leading them to believe that the company’s financial position was much stronger than it actually was.

The lawsuit alleges that Cardlytics failed to disclose that the technology company was experiencing a significant decrease in client spending, which was negatively impacting its financial performance. Additionally, the lawsuit claims that Cardlytics was facing increased competition in the market, which was further hindering its ability to generate revenue.

In light of these allegations, investors who suffered losses are encouraged to contact Levi & Korsinsky to participate in the class-action lawsuit. The law firm is dedicated to holding Cardlytics accountable for its alleged misrepresentations and ensuring that investors receive the compensation they deserve.

Investors who wish to participate in the class-action lawsuit must meet certain deadlines, including the lead plaintiff deadline of March 25, 2025. Failure to meet these deadlines may result in investors being unable to participate in the lawsuit or receive any potential compensation for their losses.

Levi & Korsinsky emphasizes the importance of investors coming forward to seek justice in cases of alleged securities fraud. By participating in the lawsuit, investors can hold companies accountable for their actions and help prevent future instances of misleading or false information being disseminated to the public.

Overall, the class-action lawsuit against Cardlytics serves as a reminder to investors to carefully scrutinize the information provided by companies before making investment decisions. Seeking legal recourse in cases of alleged securities fraud is essential to maintaining transparency and integrity in the financial markets.